![Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library](https://headachejournal.onlinelibrary.wiley.com/cms/asset/9566baed-ae13-44c5-8217-823690c29a6e/head14460-fig-0001-m.jpg)
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library
![The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization - ScienceDirect The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405844023033947-gr1.jpg)
The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization - ScienceDirect
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life - Document - Gale Academic OneFile
![JCM | Free Full-Text | Neuropsychological and Neuropsychiatric Features of Chronic Migraine Patients during the Interictal Phase JCM | Free Full-Text | Neuropsychological and Neuropsychiatric Features of Chronic Migraine Patients during the Interictal Phase](https://www.mdpi.com/jcm/jcm-12-00523/article_deploy/html/images/jcm-12-00523-g001.png)
JCM | Free Full-Text | Neuropsychological and Neuropsychiatric Features of Chronic Migraine Patients during the Interictal Phase
![Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study | Neurology and Therapy Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study | Neurology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40120-021-00305-9/MediaObjects/40120_2021_305_Fig2_HTML.png)
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study | Neurology and Therapy
![IJMS | Free Full-Text | Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations IJMS | Free Full-Text | Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations](https://pub.mdpi-res.com/ijms/ijms-24-10093/article_deploy/html/images/ijms-24-10093-g001.png?1686670192)
IJMS | Free Full-Text | Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life - Document - Gale Academic OneFile
![Real-life experiences with galcanezumab and predictors for treatment response in Turkey | springermedizin.de Real-life experiences with galcanezumab and predictors for treatment response in Turkey | springermedizin.de](https://media.springernature.com/lw367/springer-static/image/art%3A10.1186%2Fs12883-023-03467-1/MediaObjects/12883_2023_3467_Fig3_HTML.png?as=jpg)
Real-life experiences with galcanezumab and predictors for treatment response in Turkey | springermedizin.de
![Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. - Abstract - Europe PMC Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2676125/bin/422fig2.jpg)
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. - Abstract - Europe PMC
![Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study | Pain and Therapy Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-023-00538-6/MediaObjects/40122_2023_538_Fig3_HTML.png)
Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study | Pain and Therapy
![Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library](https://headachejournal.onlinelibrary.wiley.com/cms/asset/57f1507c-e5c2-4555-abc6-44f507dd8b9f/head14460-fig-0003-m.jpg)
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library
![Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial - The Lancet Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial - The Lancet](https://www.thelancet.com/cms/attachment/59456363-a245-45a5-b904-7ad5852bf722/gr1.jpg)